Latanoprost/Phentolamine

拉坦前列素/酚妥拉明

Report date: 2025/06/09 13:58:33

Base Information

Drug NameLatanoprost/Phentolamine
Drug Alias NameNyxol/latanoprostFDC-G
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors antagonistsProstanoid FP receptor agonists
TargetsProstanoid FP receptorAdrenergic receptors
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOpus Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOpus Genetics Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A